“…In this paper, we present the results of conformational studies of 4,4‐dimethyl‐1‐(trifluoromethylsulfonyl)‐1,4‐azasilinane 1 and 2,2,6,6‐tetramethyl‐4‐(trifluoromethylsulfonyl)‐1,4,2,6‐oxazadisilinane 2 as depicted in Schemes and , respectively, in comparison with our recent investigations of the reference compounds – 1‐(trifluoromethylsulfonyl)piperidine 3 as a non‐silylated analog of compound 1 , and 4‐alkyl‐2,2,6,6‐tetramethyl‐1,4,2,6‐oxazadisilinanes (alkyl = Me, 4 , or i ‐Pr, 5 ) as N‐alkyl analogs of compound 2 …”